Searchable Patents Journal

Search details
          Search details help

   Results per page

Currently viewing: Intellectual Property Office - Patents Journal : SPCs
From 2014 September 17th - 6539 to 2014 September 17th - 6539
Refine: 

  • Help on this tab
    • Page
    • Previous
    • 1
    • Next
Publication
Date
SPC No.SPC
Category
Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By"
17 September 2014
(Journal 6539)
SPC/GB01/037InvalidApplicant: Wyeth
Five Giralda Farms, Madison, New Jersey, 07940-0874, United States of America

Product: Sirolimus

Product Type: Medicinal
Authorised: CH IKS 55243 26 September 2000
UK EU/1/01/171/001-005 13 March 2001

Authorised Extension:

Patent No: EP0648494
Title: Rapamycin formulations for oral administration

SPC No: SPC/GB01/037
Date Declared Invalid: 29 September 2012
17 September 2014
(Journal 6539)
SPC/GB11/061GrantedApplicant: Bristol Myers Squibb Co.
P.O.Box 4000, Lawrenceville-Princeton Road, NJ08543-4000, United States of America

Product: Belatacept

Product Type: Medicinal
Authorised: UK EU/1/11/694/001 17 June 2011
UK EU/1/11/694/002 17 June 2011

Authorised Extension:

Patent No: EP1248802
Title: Soluble CTLA4 mutant molecules and uses thereof

SPC No: SPC/GB11/061
Date Granted: 26 August 2014
Maximum Period Expires On: 22 May 2026
17 September 2014
(Journal 6539)
SPC/GB12/035GrantedApplicant: Forest Laboratories UK Ltd.
Riverbridge House, Anchor Boulevard, Crossways, Dartford, Kent,DA2 6SL

Product: Colistimethate Sodium

Product Type: Medicinal
Authorised: UK EU/1/11/747/001 13 February 2012

Authorised Extension:

Patent No: EP1115380
Title: Micronised Pharmaceutical Compositions

SPC No: SPC/GB12/035
Date Granted: 26 August 2014
Maximum Period Expires On: 21 September 2024
17 September 2014
(Journal 6539)
SPC/GB12/043GrantedApplicant: Henry M Jackson Foundation for the Advancement of Military Medicine
1401 Rockville Pike, Suite 600, Rockville, Maryland 20852, USA

Product: Neisseria meningitidis serogroup Y polysaccharide covalently joined to tetanus toxoid carrier protein using 1-cyano-4-(dimethylamino)-pyridinium tetrafluoroborate (CDAP)

Product Type: Medicinal
Authorised: UK EU/1/12/767/001-007 20 April 2012

Authorised Extension:

Patent No: EP0720485
Title: Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs

SPC No: SPC/GB12/043
Date Granted: 21 August 2014
Maximum Period Expires On: 20 September 2019
17 September 2014
(Journal 6539)
SPC/GB13/026GrantedApplicants: Aventis Pharma S.A. and The University of British Columbia
20 avenue Raymond Aron, 92160 Antony, France

Product: Alipogene tiparvovec

Product Type: Medicinal
Authorised: UK EU/1/12/791/001 25 October 2012

Authorised Extension:

Patent No: EP0763116
Title: RECOMBINANT VIRUSES, PREPARATION AND USE THEREOF IN GENE THERAPY

SPC No: SPC/GB13/026
Date Granted: 19 August 2014
Maximum Period Expires On: 21 May 2020
17 September 2014
(Journal 6539)
SPC/GB14/057LodgedApplicant: Janssen Pharmaceutica N.V.
Turnhoutseweg 30, 2340 Beerse, Belgium

Product: Bedaquiline, or a pharmaceutically acceptable acid or base addition salt thereof, including bedaquiline fumarate

Product Type: Medicinal
Authorised: UK EU/1/13/901 7 March 2014

Authorised Extension:

Patent No: EP1527050
Title: Quinoline derivatives and their use as mycobacterial inhibitors

SPC No: SPC/GB14/057
Date Lodged: 15 August 2014
17 September 2014
(Journal 6539)
SPC/GB14/058LodgedApplicant: Zoetis W LLC
100 Campus Road, Florham Park, New Jersey 07932, United States of America

Product: Porcilis PCV The name of the product/active substance: Porcine circovirus type 2 ORF2 subunit antigen.

Product Type: Medicinal
Authorised: UK EU/2/08/091/001- 010 14 January 2009

Authorised Extension:

Patent No: EP1992696
Title: Circovirus sequences associated with porcine wasting disease (PWD)

SPC No: SPC/GB14/058
Date Lodged: 18 August 2014
17 September 2014
(Journal 6539)
SPC/GB14/059LodgedApplicant: Zoetis W LLC
100 Campus Drive, Florham Park, New Jersey 07932, United States of America

Product: Ingelvac CircoFLEX The name of the product/active substance: Porcine circovirus type 2 ORF2 protein

Product Type: Medicinal
Authorised: UK EU/2/07/079/001 15 February 2008
UK EU/2/07/079/002 15 February 2008
UK EU/2/07/079/003 15 February 2008
UK EU/2/07/079/004 15 February 2008

Authorised Extension:

Patent No: EP1992696
Title: Circovirus sequences associated with porcine wasting disease (PWD)

SPC No: SPC/GB14/059
Date Lodged: 18 August 2014
  • Page 1 of 1 (8 hits)
  • Page
  • Previous
  • 1
  • Next

Tell us about a problem